Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;22(4):421-431.
doi: 10.2174/1871525722666230907112509.

Drug-herb Synergistic Interactions between Clopidogrel and Natural Medicine

Shitang Ma  1 , Qin Zhang  2 , Jiafu Hou  3 , Shijuan Liu  3 , Chengtao Feng  4
Affiliations
Review

Drug-herb Synergistic Interactions between Clopidogrel and Natural Medicine

Shitang Ma et al. Cardiovasc Hematol Agents Med Chem. 2024.

Abstract

Introduction: Natural medicine (NM) has been used since ancient times for therapeutic purposes worldwide. Presently, the combination of clopidogrel and NM with a reasonable synergistic effect has gained increasing acceptance in clinical therapeutics.

Methods: Here, we have performed a comprehensive retrieval of literature published in both English and Chinese databases until August 1, 2022, studying the synergistic interactions of clopidogrel and NM through pharmacokinetic/pharmacodynamic (PK-PD) analyses. We retrieved 7, 3, and 5 studies on PK analysis and 3, 3, and 8 studies on PD analysis for the interaction of clopidogrel with single herbal medicines, bioactive compounds, and herbal prescriptions, respectively. Most studies on NM have been found to mainly focus on preclinical observations, and there have been fewer clinical PK analyses.

Results: A potential drug-herb interaction has been observed to occur when clopidogrel and NM were metabolized by an enzyme network comprising P-gp, CES1, and CYP450. In contrast, most PD studies have focused on clinical observations, and few preclinical findings have been reported. Some cases have suggested that the combination of the two types of drugs would alter the antiplatelet efficacy and adverse effects. Studies on PK, however, have shown significant or slightly varying results for the drug prototype and its metabolites.

Conclusion: In the combination therapies, the interaction between clopidogrel and NM was found to alter antiplatelet aggregation pathways and P2Y12 receptor function.

Keywords: Natural medicine; clinical therapeutics.; clopidogrel; pharmacodynamic; pharmacokinetic; synergistic effect.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Feigin V.L.; Stark B.A.; Johnson C.O.; Roth G.A.; Bisignano C.; Abady G.G.; Abbasifard M.; Abbasi-Kangevari M.; Abd-Allah F.; Abedi V.; Abualhasan A.; Abu-Rmeileh N.M.E.; Abushouk A.I.; Adebayo O.M.; Agarwal G.; Agasthi P.; Ahinkorah B.O.; Ahmad S.; Ahmadi S.; Ahmed Salih Y.; Aji B.; Akbarpour S.; Akinyemi R.O.; Al Hamad H.; Alahdab F.; Alif S.M.; Alipour V.; Aljunid S.M.; Almustanyir S.; Al-Raddadi R.M.; Al-Shahi Salman R.; Alvis-Guzman N.; Ancuceanu R.; Anderlini D.; Anderson J.A.; Ansar A.; Antonazzo I.C.; Arabloo J.; Ärnlöv J.; Artanti K.D.; Aryan Z.; Asgari S.; Ashraf T.; Athar M.; Atreya A.; Ausloos M.; Baig A.A.; Baltatu O.C.; Banach M.; Barboza M.A.; Barker-Collo S.L.; Bärnighausen T.W.; Barone M.T.U.; Basu S.; Bazmandegan G.; Beghi E.; Beheshti M.; Béjot Y.; Bell A.W.; Bennett D.A.; Bensenor I.M.; Bezabhe W.M.; Bezabih Y.M.; Bhagavathula A.S.; Bhardwaj P.; Bhattacharyya K.; Bijani A.; Bikbov B.; Birhanu M.M.; Boloor A.; Bonny A.; Brauer M.; Brenner H.; Bryazka D.; Butt Z.A.; Caetano dos Santos F.L.; Campos-Nonato I.R.; Cantu-Brito C.; Carrero J.J.; Castañeda-Orjuela C.A.; Catapano A.L.; Chakraborty P.A.; Charan J.; Choudhari S.G.; Chowdhury E.K.; Chu D-T.; Chung S-C.; Colozza D.; Costa V.M.; Costanzo S.; Criqui M.H.; Dadras O.; Dagnew B.; Dai X.; Dalal K.; Damasceno A.A.M.; D’Amico E.; Dandona L.; Dandona R.; Darega Gela J.; Davletov K.; De la Cruz-Góngora V.; Desai R.; Dhamnetiya D.; Dharmaratne S.D.; Dhimal M.L.; Dhimal M.; Diaz D.; Dichgans M.; Dokova K.; Doshi R.; Douiri A.; Duncan B.B.; Eftekharzadeh S.; Ekholuenetale M.; El Nahas N.; Elgendy I.Y.; Elhadi M.; El-Jaafary S.I.; Endres M.; Endries A.Y.; Erku D.A.; Faraon E.J.A.; Farooque U.; Farzadfar F.; Feroze A.H.; Filip I.; Fischer F.; Flood D.; Gad M.M.; Gaidhane S.; Ghanei Gheshlagh R.; Ghashghaee A.; Ghith N.; Ghozali G.; Ghozy S.; Gialluisi A.; Giampaoli S.; Gilani S.A.; Gill P.S.; Gnedovskaya E.V.; Golechha M.; Goulart A.C.; Guo Y.; Gupta R.; Gupta V.B.; Gupta V.K.; Gyanwali P.; Hafezi-Nejad N.; Hamidi S.; Hanif A.; Hankey G.J.; Hargono A.; Hashi A.; Hassan T.S.; Hassen H.Y.; Havmoeller R.J.; Hay S.I.; Hayat K.; Hegazy M.I.; Herteliu C.; Holla R.; Hostiuc S.; Househ M.; Huang J.; Humayun A.; Hwang B-F.; Iacoviello L.; Iavicoli I.; Ibitoye S.E.; Ilesanmi O.S.; Ilic I.M.; Ilic M.D.; Iqbal U.; Irvani S.S.N.; Islam S.M.S.; Ismail N.E.; Iso H.; Isola G.; Iwagami M.; Jacob L.; Jain V.; Jang S-I.; Jayapal S.K.; Jayaram S.; Jayawardena R.; Jeemon P.; Jha R.P.; Johnson W.D.; Jonas J.B.; Joseph N.; Jozwiak J.J.; Jürisson M.; Kalani R.; Kalhor R.; Kalkonde Y.; Kamath A.; Kamiab Z.; Kanchan T.; Kandel H.; Karch A.; Katoto P.D.M.C.; Kayode G.A.; Keshavarz P.; Khader Y.S.; Khan E.A.; Khan I.A.; Khan M.; Khan M.A.B.; Khatib M.N.; Khubchandani J.; Kim G.R.; Kim M.S.; Kim Y.J.; Kisa A.; Kisa S.; Kivimäki M.; Kolte D.; Koolivand A.; Koulmane Laxminarayana S.L.; Koyanagi A.; Krishan K.; Krishnamoorthy V.; Krishnamurthi R.V.; Kumar G.A.; Kusuma D.; La Vecchia C.; Lacey B.; Lak H.M.; Lallukka T.; Lasrado S.; Lavados P.M.; Leonardi M.; Li B.; Li S.; Lin H.; Lin R-T.; Liu X.; Lo W.D.; Lorkowski S.; Lucchetti G.; Lutzky Saute R.; Magdy Abd El Razek H.; Magnani F.G.; Mahajan P.B.; Majeed A.; Makki A.; Malekzadeh R.; Malik A.A.; Manafi N.; Mansournia M.A.; Mantovani L.G.; Martini S.; Mazzaglia G.; Mehndiratta M.M.; Menezes R.G.; Meretoja A.; Mersha A.G.; Miao Jonasson J.; Miazgowski B.; Miazgowski T.; Michalek I.M.; Mirrakhimov E.M.; Mohammad Y.; Mohammadian-Hafshejani A.; Mohammed S.; Mokdad A.H.; Mokhayeri Y.; Molokhia M.; Moni M.A.; Montasir A.A.; Moradzadeh R.; Morawska L.; Morze J.; Muruet W.; Musa K.I.; Nagarajan A.J.; Naghavi M.; Narasimha Swamy S.; Nascimento B.R.; Negoi R.I.; Neupane Kandel S.; Nguyen T.H.; Norrving B.; Noubiap J.J.; Nwatah V.E.; Oancea B.; Odukoya O.O.; Olagunju A.T.; Orru H.; Owolabi M.O.; Padubidri J.R.; Pana A.; Parekh T.; Park E-C.; Pashazadeh Kan F.; Pathak M.; Peres M.F.P.; Perianayagam A.; Pham T-M.; Piradov M.A.; Podder V.; Polinder S.; Postma M.J.; Pourshams A.; Radfar A.; Rafiei A.; Raggi A.; Rahim F.; Rahimi-Movaghar V.; Rahman M.; Rahman M.A.; Rahmani A.M.; Rajai N.; Ranasinghe P.; Rao C.R.; Rao S.J.; Rathi P.; Rawaf D.L.; Rawaf S.; Reitsma M.B.; Renjith V.; Renzaho A.M.N.; Rezapour A.; Rodriguez J.A.B.; Roever L.; Romoli M.; Rynkiewicz A.; Sacco S.; Sadeghi M.; Saeedi Moghaddam S.; Sahebkar A.; Saif-Ur-Rahman K.M.; Salah R.; Samaei M.; Samy A.M.; Santos I.S.; Santric-Milicevic M.M.; Sarrafzadegan N.; Sathian B.; Sattin D.; Schiavolin S.; Schlaich M.P.; Schmidt M.I.; Schutte A.E.; Sepanlou S.G.; Seylani A.; Sha F.; Shahabi S.; Shaikh M.A.; Shannawaz M.; Shawon M.S.R.; Sheikh A.; Sheikhbahaei S.; Shibuya K.; Siabani S.; Silva D.A.S.; Singh J.A.; Singh J.K.; Skryabin V.Y.; Skryabina A.A.; Sobaih B.H.; Stortecky S.; Stranges S.; Tadesse E.G.; Tarigan I.U.; Temsah M-H.; Teuschl Y.; Thrift A.G.; Tonelli M.; Tovani-Palone M.R.; Tran B.X.; Tripathi M.; Tsegaye G.W.; Ullah A.; Unim B.; Unnikrishnan B.; Vakilian A.; Valadan Tahbaz S.; Vasankari T.J.; Venketasubramanian N.; Vervoort D.; Vo B.; Volovici V.; Vosoughi K.; Vu G.T.; Vu L.G.; Wafa H.A.; Waheed Y.; Wang Y.; Wijeratne T.; Winkler A.S.; Wolfe C.D.A.; Woodward M.; Wu J.H.; Wulf Hanson S.; Xu X.; Yadav L.; Yadollahpour A.; Yahyazadeh Jabbari S.H.; Yamagishi K.; Yatsuya H.; Yonemoto N.; Yu C.; Yunusa I.; Zaman M.S.; Zaman S.B.; Zamanian M.; Zand R.; Zandifar A.; Zastrozhin M.S.; Zastrozhina A.; Zhang Y.; Zhang Z-J.; Zhong C.; Zuniga Y.M.H.; Murray C.J.L.; Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021,20(10),795-820 - DOI - PubMed
    1. Scheitz J.F.; Sposato L.A.; Schulz-Menger J.; Nolte C.H.; Backs J.; Endres M.; Stroke-heart syndrome: Recent Advances and Challenges. J Am Heart Assoc 2022,11(17),e026528 - DOI - PubMed
    1. Matsumaru Y.; Kitazono T.; Kadota K.; Nakao K.; Nakagawa Y.; Shite J.; Yokoi H.; Kozuma K.; Tanabe K.; Akasaka T.; Shinke T.; Ueno T.; Hirayama A.; Uemura S.; Kuroda T.; Takita A.; Harada A.; Iijima R.; Murakami Y.; Saito S.; Nakamura M.; Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: A PENDULUM analysis. Heart Vessels 2022,37(6),942-953 - DOI - PubMed
    1. Khalil P.; Kabbach G.; Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: A review. Curr Cardiol Rep 2019,21(1),5 - DOI - PubMed
    1. Motovska Z.; Kala P.; Benefits and risks of clopidogrel use in patients with coronary artery disease: Evidence from randomized studies and registries. Clin Ther 2008,30(Pt 2),2191-2202 - DOI - PubMed

MeSH terms

LinkOut - more resources